|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
multiple interactions |
ISO |
[ABCC1 gene mutant form results in increased hydroxylation of Testosterone] which results in increased chemical synthesis of 16-hydroxytestosterone |
CTD |
PMID:22522787 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
UGT2B15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of 16-hydroxytestosterone |
CTD |
PMID:7835232 |
|
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression multiple interactions increases export |
EXP |
Estriol results in increased expression of ABCB1 mRNA; Estriol results in increased expression of ABCB1 protein Elacridar inhibits the reaction [ABCB1 protein results in increased export of Estriol] |
CTD |
PMID:15290871 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
multiple interactions increases expression |
EXP |
fulvestrant inhibits the reaction [Estriol results in increased expression of ABCG2 mRNA]; fulvestrant inhibits the reaction [Estriol results in increased expression of ABCG2 protein] Estriol results in increased expression of ABCG2 mRNA; Estriol results in increased expression of ABCG2 protein |
CTD |
PMID:16849015 PMID:17823853 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ACRBP |
acrosin binding protein |
decreases expression |
ISO |
Estriol results in decreased expression of ACRBP mRNA |
CTD |
PMID:25575267 |
|
NCBI chr12:6,638,075...6,647,432
Ensembl chr12:6,638,075...6,647,433
|
|
G |
ACTC1 |
actin alpha cardiac muscle 1 |
affects expression |
EXP |
Estriol affects the expression of ACTC1 mRNA |
CTD |
PMID:23184660 |
|
NCBI chr15:34,790,230...34,795,549
Ensembl chr15:34,790,107...34,795,589
|
|
G |
AFP |
alpha fetoprotein |
increases expression affects binding |
EXP ISO |
Estriol results in increased expression of AFP protein Estriol binds to AFP protein |
CTD |
PMID:2470397 PMID:18497072 PMID:23013281 PMID:25349334 |
|
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
increases expression |
EXP |
Estriol results in increased expression of AGER protein |
CTD |
PMID:15878629 |
|
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
AGTR1 |
angiotensin II receptor type 1 |
decreases expression |
EXP |
Estriol results in decreased expression of AGTR1 mRNA |
CTD |
PMID:15159206 |
|
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
|
|
G |
AKAP17A |
A-kinase anchoring protein 17A |
decreases expression |
ISO |
Estriol results in decreased expression of AKAP17B mRNA |
CTD |
PMID:25575267 |
|
NCBI chr X:1,591,604...1,602,520 NCBI chr Y:1,591,604...1,602,520
Ensembl chr Y:1,591,604...1,602,520 Ensembl chr X:1,591,604...1,602,520
|
|
G |
AKIRIN1 |
akirin 1 |
increases expression |
ISO |
Estriol results in increased expression of AKIRIN1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 1:38,991,276...39,006,059
Ensembl chr 1:38,991,276...39,006,059
|
|
G |
ALB |
albumin |
decreases expression |
ISO |
Estriol results in decreased expression of ALB protein |
CTD |
PMID:2470397 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
AMER1 |
APC membrane recruitment protein 1 |
decreases expression |
ISO |
Estriol results in decreased expression of AMER1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr X:64,185,117...64,205,708
Ensembl chr X:64,185,117...64,205,708
|
|
G |
AR |
androgen receptor |
affects binding multiple interactions |
ISO EXP |
Estriol binds to AR protein Estriol inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; Estriol inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:14565775 PMID:18324785 PMID:28803809 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ARHGDIA |
Rho GDP dissociation inhibitor alpha |
decreases expression |
EXP |
Estriol results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:15159206 |
|
NCBI chr17:81,867,721...81,871,337
Ensembl chr17:81,867,719...81,871,378
|
|
G |
AURKB |
aurora kinase B |
increases expression |
ISO |
Estriol results in increased expression of AURKB mRNA |
CTD |
PMID:25575267 |
|
NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
|
|
G |
B3GNTL1 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1 |
decreases expression |
ISO |
Estriol results in decreased expression of B3GNTL1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr17:82,942,149...83,051,770
Ensembl chr17:82,942,149...83,051,809
|
|
G |
B4GALT1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
EXP |
Estriol results in increased expression of B4GALT1 mRNA |
CTD |
PMID:14605097 |
|
NCBI chr 9:33,104,077...33,185,089
Ensembl chr 9:33,100,493...33,167,336
|
|
G |
BMF |
Bcl2 modifying factor |
decreases expression |
ISO |
Estriol results in decreased expression of BMF mRNA |
CTD |
PMID:25575267 |
|
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
|
|
G |
BTBD10 |
BTB domain containing 10 |
increases expression |
ISO |
Estriol results in increased expression of BTBD10 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr11:13,388,008...13,463,222
Ensembl chr11:13,388,008...13,463,297
|
|
G |
C2CD2L |
C2CD2 like |
increases expression |
ISO |
Estriol results in increased expression of C2CD2L mRNA |
CTD |
PMID:25575267 |
|
NCBI chr11:119,102,249...119,118,544
Ensembl chr11:119,102,198...119,118,544
|
|
G |
CCN1 |
cellular communication network factor 1 |
increases expression |
ISO |
Estriol results in increased expression of CCN1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
|
|
G |
CCNB1 |
cyclin B1 |
increases expression |
ISO |
Estriol results in increased expression of CCNB1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCNB2 |
cyclin B2 |
increases expression |
ISO |
Estriol results in increased expression of CCNB2 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
|
|
G |
CCNE1 |
cyclin E1 |
multiple interactions |
EXP |
Estriol inhibits the reaction [Estradiol results in increased cleavage of CCNE1 protein] |
CTD |
PMID:23624423 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CD274 |
CD274 molecule |
increases expression |
ISO |
Estriol results in increased expression of CD274 protein |
CTD |
PMID:21317386 |
|
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
|
|
G |
CD276 |
CD276 molecule |
increases expression |
ISO |
Estriol results in increased expression of CD276 protein |
CTD |
PMID:21317386 |
|
NCBI chr15:73,683,944...73,714,514
Ensembl chr15:73,683,966...73,714,514
|
|
G |
CD80 |
CD80 molecule |
increases expression |
ISO |
Estriol results in increased expression of CD80 protein |
CTD |
PMID:21317386 |
|
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
CD86 |
CD86 molecule |
increases expression |
ISO |
Estriol results in increased expression of CD86 protein |
CTD |
PMID:21317386 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CD99L2 |
CD99 molecule like 2 |
decreases expression |
ISO |
Estriol results in decreased expression of CD99L2 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr X:150,766,336...150,898,668
Ensembl chr X:150,766,336...150,898,816
|
|
G |
CDC42SE1 |
CDC42 small effector 1 |
increases expression |
ISO |
Estriol results in increased expression of CDC42SE1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 1:151,050,985...151,059,622
Ensembl chr 1:151,050,971...151,070,325
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
ISO |
Estriol results in increased expression of CDKN1A mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CHST8 |
carbohydrate sulfotransferase 8 |
increases expression |
ISO |
Estriol results in increased expression of CHST8 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr19:33,621,953...33,773,509
Ensembl chr19:33,621,953...33,773,509
|
|
G |
CKB |
creatine kinase B |
increases expression |
ISO |
Estriol results in increased expression of CKB |
CTD |
PMID:10030690 |
|
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
|
|
G |
CNRIP1 |
cannabinoid receptor interacting protein 1 |
decreases expression |
ISO |
Estriol results in decreased expression of CNRIP1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 2:68,284,171...68,319,949
Ensembl chr 2:68,284,171...68,320,051
|
|
G |
CRISPLD2 |
cysteine rich secretory protein LCCL domain containing 2 |
increases expression |
ISO |
Estriol results in increased expression of CRISPLD2 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr16:84,819,985...84,909,508
Ensembl chr16:84,819,985...84,920,768
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
multiple interactions decreases expression |
EXP |
Estriol inhibits the reaction [Aflatoxin B1 results in increased expression of CYP19A1 mRNA] Estriol results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:21296134 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions |
ISO |
Estriol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Estriol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Estriol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] |
CTD |
PMID:12093619 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
increases expression |
ISO |
Estriol results in increased expression of CYP2B10 mRNA |
CTD |
PMID:7771797 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP3A7 |
cytochrome P450 family 3 subfamily A member 7 |
multiple interactions |
EXP |
Estriol inhibits the reaction [imidacloprid results in increased expression of CYP3A7]; Estriol inhibits the reaction [thiacloprid results in increased expression of CYP3A7]; Estriol inhibits the reaction [thiamethoxam results in increased expression of CYP3A7] |
CTD |
PMID:28750898 |
|
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
|
|
G |
DENND2A |
DENN domain containing 2A |
increases expression |
ISO |
Estriol results in increased expression of DENND2A mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 7:140,518,419...140,641,460
Ensembl chr 7:140,518,420...140,673,993
|
|
G |
DTX4 |
deltex E3 ubiquitin ligase 4 |
decreases expression |
ISO |
Estriol results in decreased expression of DTX4 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr11:59,171,430...59,208,588
Ensembl chr11:59,171,430...59,208,588
|
|
G |
EEIG1 |
estrogen-induced osteoclastogenesis regulator 1 |
increases expression |
EXP |
Estriol results in increased expression of EEIG1 mRNA |
CTD |
PMID:14605097 |
|
NCBI chr 9:127,940,582...127,980,989
Ensembl chr 9:127,940,582...127,980,989
|
|
G |
EGR1 |
early growth response 1 |
increases expression |
ISO |
Estriol results in increased expression of EGR1 mRNA |
CTD |
PMID:1717835 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EGR3 |
early growth response 3 |
increases expression |
EXP |
Estriol results in increased expression of EGR3 mRNA |
CTD |
PMID:15159206 |
|
NCBI chr 8:22,687,659...22,693,480
Ensembl chr 8:22,687,659...22,693,480
|
|
G |
EIF2S2 |
eukaryotic translation initiation factor 2 subunit beta |
increases expression |
ISO |
Estriol results in increased expression of EIF2S2 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,243
|
|
G |
ENO2 |
enolase 2 |
decreases expression |
EXP |
Estriol results in decreased expression of ENO2 mRNA |
CTD |
PMID:15159206 |
|
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions affects binding increases activity affects localization increases expression |
EXP ISO |
Estriol binds to and results in increased activity of ESR1 protein; Estriol inhibits the reaction [16 alpha-iodoestradiol binds to ESR1 protein]; Estriol inhibits the reaction [Estradiol binds to ESR1 protein]; Estriol promotes the reaction [ESR1 protein binds to ESR1 protein]; Fulvestrant inhibits the reaction [Estriol results in increased activity of ESR1 protein] Estriol binds to ESR1 protein Estriol affects the localization of ESR1 protein Estriol results in increased expression of ESR1 mRNA |
CTD |
PMID:9048584 PMID:11162928 PMID:11518614 PMID:12127041 PMID:12598185 PMID:15026083 PMID:18026938 PMID:19820872 PMID:19913605 PMID:20950447 PMID:22562034 PMID:29783106 PMID:33049310 More...
|
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ESR2 |
estrogen receptor 2 |
multiple interactions affects binding |
EXP ISO |
Estriol binds to and results in increased activity of ESR2 protein; Estriol inhibits the reaction [Estradiol binds to ESR2 protein] Estriol binds to Esr2 protein Estriol binds to ESR2 protein Estriol inhibits the reaction [16 alpha-iodoestradiol binds to ESR2 protein]; Estriol inhibits the reaction [Estradiol binds to ESR2 protein alternative form]; Estriol inhibits the reaction [Estradiol binds to ESR2 protein] |
CTD RGD |
PMID:8650195 PMID:9048584 PMID:9492041 PMID:9751507 PMID:11518614 PMID:12547825 PMID:16728493 PMID:19913605 PMID:33049310 PMID:9048584 More...
|
RGD:8694130 |
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
ETF1 |
eukaryotic translation termination factor 1 |
increases expression |
ISO |
Estriol results in increased expression of ETF1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 5:138,506,095...138,543,236
Ensembl chr 5:138,506,095...138,543,236
|
|
G |
F10 |
coagulation factor X |
increases expression |
EXP |
Estriol results in increased expression of F10 protein |
CTD |
PMID:614942 |
|
NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,799...113,149,529
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Estriol results in increased expression of FOS mRNA |
CTD |
PMID:2118345 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FOXA2 |
forkhead box A2 |
increases expression |
EXP |
Estriol results in increased expression of FOXA2 mRNA |
CTD |
PMID:23184660 |
|
NCBI chr20:22,580,998...22,585,490
Ensembl chr20:22,580,998...22,585,455
|
|
G |
GH1 |
growth hormone 1 |
increases expression |
ISO |
Estriol results in increased expression of GH1 mRNA |
CTD |
PMID:15240998 |
|
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
decreases expression |
EXP |
Estriol results in decreased expression of HNF4A mRNA |
CTD |
PMID:23184660 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
HOXA10 |
homeobox A10 |
decreases expression |
ISO |
Estriol results in decreased expression of HOXA10 mRNA |
CTD |
PMID:16402032 |
|
NCBI chr 7:27,170,605...27,179,861
Ensembl chr 7:27,170,605...27,180,261
|
|
G |
HOXA11 |
homeobox A11 |
decreases expression |
ISO |
Estriol results in decreased expression of HOXA11 mRNA |
CTD |
PMID:16402032 |
|
NCBI chr 7:27,181,157...27,185,232
Ensembl chr 7:27,181,157...27,185,232
|
|
G |
IFNG |
interferon gamma |
decreases expression multiple interactions |
ISO |
Estriol results in decreased expression of IFNG protein Estriol inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] |
CTD |
PMID:11063824 PMID:21317386 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IGF1 |
insulin like growth factor 1 |
increases expression |
EXP |
Estriol results in increased expression of IGF1 mRNA |
CTD |
PMID:15969240 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGFBP5 |
insulin like growth factor binding protein 5 |
decreases expression |
EXP |
Estriol results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:15159206 |
|
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
|
|
G |
IL10 |
interleukin 10 |
increases expression |
ISO |
Estriol results in increased expression of IL10 mRNA |
CTD |
PMID:21317386 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12A |
interleukin 12A |
increases expression |
ISO |
Estriol results in increased expression of IL12A mRNA |
CTD |
PMID:21317386 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
decreases expression |
ISO |
Estriol results in decreased expression of IL12B mRNA |
CTD |
PMID:21317386 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL1A |
interleukin 1 alpha |
decreases expression |
EXP |
Estriol results in decreased expression of IL1A mRNA |
CTD |
PMID:10731640 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL23A |
interleukin 23 subunit alpha |
decreases expression |
ISO |
Estriol results in decreased expression of IL23A mRNA |
CTD |
PMID:21317386 |
|
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
|
|
G |
IL4 |
interleukin 4 |
increases expression |
ISO |
Estriol results in increased expression of IL4 protein |
CTD |
PMID:21317386 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL6 |
interleukin 6 |
decreases expression multiple interactions |
EXP ISO |
Estriol results in decreased expression of IL6 mRNA Estriol affects the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Estriol affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Estriol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Tamoxifen inhibits the reaction [Estriol affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]] |
CTD |
PMID:8979148 PMID:10731640 PMID:21317386 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INHBB |
inhibin subunit beta B |
increases expression |
ISO |
Estriol results in increased expression of INHBB mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
|
|
G |
IP6K2 |
inositol hexakisphosphate kinase 2 |
decreases expression |
ISO |
Estriol results in decreased expression of IP6K2 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 3:48,688,003...48,717,221
Ensembl chr 3:48,688,003...48,740,353
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Estriol results in increased expression of JUN mRNA |
CTD |
PMID:2118345 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
LPAR4 |
lysophosphatidic acid receptor 4 |
decreases expression |
ISO |
Estriol results in decreased expression of LPAR4 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr X:78,747,720...78,758,714
Ensembl chr X:78,747,709...78,758,714
|
|
G |
LSM10 |
LSM10, U7 small nuclear RNA associated |
decreases expression |
ISO |
Estriol results in decreased expression of LSM10 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 1:36,393,436...36,397,908
Ensembl chr 1:36,391,238...36,397,908
|
|
G |
MAK16 |
MAK16 homolog |
increases expression |
ISO |
Estriol results in increased expression of RBM13 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 8:33,485,182...33,501,262
Ensembl chr 8:33,485,182...33,501,262
|
|
G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
increases expression |
ISO |
Estriol results in increased expression of MAP2K1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation affects phosphorylation |
ISO |
4-ethylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; 4-nonylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; 4-octylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; 4-propylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; bisphenol A inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein] Estriol affects the phosphorylation of MAPK1 protein 4-ethylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK1 protein]; 4-nonylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK1 protein]; 4-octylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK1 protein]; 4-propylphenol affects the reaction [Estriol affects the phosphorylation of MAPK1 protein]; bisphenol A affects the reaction [Estriol affects the phosphorylation of MAPK1 protein]; fulvestrant inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; NF023 inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; Nystatin inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein]; Pertussis Toxin inhibits the reaction [Estriol results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:20870566 PMID:20950447 PMID:22230296 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation affects phosphorylation |
ISO |
4-ethylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; 4-nonylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; 4-octylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; 4-propylphenol inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; bisphenol A inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein] Estriol affects the phosphorylation of MAPK3 protein 4-ethylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK3 protein]; 4-nonylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK3 protein]; 4-octylphenol analog affects the reaction [Estriol affects the phosphorylation of MAPK3 protein]; 4-propylphenol affects the reaction [Estriol affects the phosphorylation of MAPK3 protein]; bisphenol A affects the reaction [Estriol affects the phosphorylation of MAPK3 protein]; fulvestrant inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; NF023 inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; Nystatin inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein]; Pertussis Toxin inhibits the reaction [Estriol results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:20870566 PMID:20950447 PMID:22230296 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
Estriol results in increased expression of MYC mRNA |
CTD |
PMID:2118345 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
NAMPT |
nicotinamide phosphoribosyltransferase |
increases expression multiple interactions |
ISO |
Estriol results in increased expression of NAMPT mRNA [Estradiol co-treated with Progesterone] promotes the reaction [Estriol results in increased expression of NAMPT mRNA] |
CTD |
PMID:20004694 |
|
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions decreases expression |
ISO |
Estriol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Estriol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] Estriol results in decreased expression of NOS2 mRNA |
CTD |
PMID:11063824 PMID:21317386 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
increases expression |
EXP |
Estriol results in increased expression of NOS3 mRNA; Estriol results in increased expression of NOS3 protein |
CTD |
PMID:12547825 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NPPC |
natriuretic peptide C |
increases expression |
ISO |
Estriol results in increased expression of NPPC protein |
CTD |
PMID:9435603 |
|
NCBI chr 2:231,921,809...231,926,396
Ensembl chr 2:231,921,809...231,926,396
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
multiple interactions |
EXP |
Estriol binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
|
|
G |
NUP50 |
nucleoporin 50 |
increases expression |
ISO |
Estriol results in increased expression of NUP50 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr22:45,163,925...45,188,017
Ensembl chr22:45,163,925...45,188,017
|
|
G |
PDCD1LG2 |
programmed cell death 1 ligand 2 |
increases expression |
ISO |
Estriol results in increased expression of PDCD1LG2 protein |
CTD |
PMID:21317386 |
|
NCBI chr 9:5,510,531...5,571,282
Ensembl chr 9:5,510,531...5,571,282
|
|
G |
PDE12 |
phosphodiesterase 12 |
increases expression |
ISO |
Estriol results in increased expression of PDE12 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 3:57,556,274...57,656,495
Ensembl chr 3:57,556,274...57,656,480
|
|
G |
PDGFA |
platelet derived growth factor subunit A |
decreases expression |
EXP |
Estriol results in decreased expression of PDGFA mRNA |
CTD |
PMID:10731640 |
|
NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
|
|
G |
PDZK1 |
PDZ domain containing 1 |
increases expression |
EXP |
Estriol results in increased expression of PDZK1 mRNA |
CTD |
PMID:14605097 PMID:15159206 |
|
NCBI chr 1:145,670,852...145,707,400
Ensembl chr 1:145,670,852...145,708,148
|
|
G |
PGR |
progesterone receptor |
increases expression |
EXP |
Estriol results in increased expression of PGR mRNA |
CTD |
PMID:19820872 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PIK3IP1 |
phosphoinositide-3-kinase interacting protein 1 |
decreases expression |
ISO |
Estriol results in decreased expression of PIK3IP1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr22:31,281,593...31,292,534
Ensembl chr22:31,281,594...31,292,534
|
|
G |
POLG2 |
DNA polymerase gamma 2, accessory subunit |
decreases expression |
ISO |
Estriol results in decreased expression of POLG2 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr17:64,477,785...64,497,054
Ensembl chr17:64,477,785...64,497,054
|
|
G |
PPP1R15B |
protein phosphatase 1 regulatory subunit 15B |
increases expression |
ISO |
Estriol results in increased expression of PPP1R15B mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 1:204,395,826...204,411,817
Ensembl chr 1:204,396,492...204,411,887
|
|
G |
PPP4R1 |
protein phosphatase 4 regulatory subunit 1 |
increases expression |
ISO |
Estriol results in increased expression of PPP4R1 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr18:9,546,794...9,617,199
Ensembl chr18:9,546,791...9,615,240
|
|
G |
PRL |
prolactin |
increases expression increases secretion multiple interactions |
ISO |
Estriol results in increased expression of PRL mRNA; Estriol results in increased expression of PRL protein Estriol results in increased secretion of PRL protein 4-ethylphenol affects the reaction [Estriol results in increased secretion of PRL protein]; 4-nonylphenol affects the reaction [Estriol results in increased secretion of PRL protein]; 4-octylphenol affects the reaction [Estriol results in increased secretion of PRL protein]; 4-propylphenol affects the reaction [Estriol results in increased secretion of PRL protein]; bisphenol A affects the reaction [Estriol results in increased secretion of PRL protein] Estriol promotes the reaction [Estradiol results in increased expression of PRL mRNA] |
CTD |
PMID:3780563 PMID:3996322 PMID:7306549 PMID:20950447 |
|
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
|
|
G |
PRRX2 |
paired related homeobox 2 |
increases expression |
ISO |
Estriol results in increased expression of PRRX2 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 9:129,665,647...129,722,674
Ensembl chr 9:129,665,647...129,722,674
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Estriol inhibits the reaction [TNF protein affects the localization of RELA protein] |
CTD |
PMID:12547825 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RRP1B |
ribosomal RNA processing 1B |
increases expression |
ISO |
Estriol results in increased expression of RRP1B mRNA |
CTD |
PMID:25575267 |
|
NCBI chr21:43,659,560...43,696,079
Ensembl chr21:43,659,560...43,696,079
|
|
G |
SDC3 |
syndecan 3 |
increases expression |
ISO |
Estriol results in increased expression of SDC3 mRNA |
CTD |
PMID:11024013 |
|
NCBI chr 1:30,869,466...30,909,735
Ensembl chr 1:30,869,466...30,908,758
|
|
G |
SELENBP1 |
selenium binding protein 1 |
decreases expression |
EXP |
Estriol results in decreased expression of SELENBP1 mRNA |
CTD |
PMID:15159206 |
|
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
|
|
G |
SHBG |
sex hormone binding globulin |
affects binding |
EXP |
Estriol binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr17:7,614,064...7,633,372
Ensembl chr17:7,613,946...7,633,382
|
|
G |
SIRT3 |
sirtuin 3 |
decreases expression |
ISO |
Estriol results in decreased expression of SIRT3 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
|
|
G |
SLC12A2 |
solute carrier family 12 member 2 |
decreases expression |
EXP |
Estriol results in decreased expression of SLC12A2 mRNA |
CTD |
PMID:15159206 |
|
NCBI chr 5:128,083,766...128,189,677
Ensembl chr 5:128,083,766...128,189,677
|
|
G |
SLC7A11 |
solute carrier family 7 member 11 |
increases expression |
EXP |
Estriol results in increased expression of SLC7A11 mRNA |
CTD |
PMID:15159206 |
|
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
|
|
G |
SLC7A6 |
solute carrier family 7 member 6 |
increases expression |
ISO |
Estriol results in increased expression of SLC7A6 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr16:68,264,526...68,301,819
Ensembl chr16:68,264,516...68,301,823
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
increases expression |
ISO |
Estriol results in increased expression of SOCS3 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
|
|
G |
STAT5A |
signal transducer and activator of transcription 5A |
increases expression |
ISO |
Estriol results in increased expression of STAT5A mRNA |
CTD |
PMID:25575267 |
|
NCBI chr17:42,287,439...42,311,943
Ensembl chr17:42,287,547...42,311,943
|
|
G |
SULT1E1 |
sulfotransferase family 1E member 1 |
decreases activity |
EXP |
Estriol results in decreased activity of SULT1E1 protein |
CTD |
PMID:16914110 |
|
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
|
|
G |
SYNPO |
synaptopodin |
increases expression |
ISO |
Estriol results in increased expression of SYNPO mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 5:150,586,010...150,659,207
Ensembl chr 5:150,601,080...150,659,207
|
|
G |
TBX19 |
T-box transcription factor 19 |
decreases abundance |
EXP |
TBX19 gene mutant form results in decreased abundance of Estriol |
CTD |
PMID:16390921 |
|
NCBI chr 1:168,280,877...168,314,426
Ensembl chr 1:168,280,877...168,314,426
|
|
G |
TFF1 |
trefoil factor 1 |
increases expression multiple interactions |
EXP |
Estriol results in increased expression of TFF1 mRNA fulvestrant inhibits the reaction [Estriol results in increased expression of TFF1 mRNA] |
CTD |
PMID:22562034 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
increases expression |
ISO |
Estriol results in increased expression of TGFB1 mRNA |
CTD |
PMID:21317386 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
THRA |
thyroid hormone receptor alpha |
decreases expression |
ISO |
Estriol results in decreased expression of THRA mRNA |
CTD |
PMID:25575267 |
|
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
|
|
G |
TMEM183A |
transmembrane protein 183A |
increases expression |
ISO |
Estriol results in increased expression of TMEM183A mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 1:203,007,374...203,024,848
Ensembl chr 1:203,007,374...203,024,848
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
EXP ISO |
Estriol inhibits the reaction [TNF protein affects the localization of RELA protein]; Estriol inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Estriol inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Fulvestrant inhibits the reaction [Estriol inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] estriol enhances the reaction [lipopolysaccharide increases expression of Tnf mRNA in liver and protein in serum] Estriol affects the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Estriol inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide]; Estriol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Estriol promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Tamoxifen inhibits the reaction [Estriol promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]] |
CTD RGD |
PMID:8979148 PMID:11063824 PMID:12547825 PMID:9575848 |
RGD:15017096 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TXNIP |
thioredoxin interacting protein |
decreases expression |
ISO |
Estriol results in decreased expression of TXNIP mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
|
|
G |
TYR |
tyrosinase |
multiple interactions |
ISO |
Estriol inhibits the reaction [imidazole results in increased expression of TYR protein] |
CTD |
PMID:3127403 |
|
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
|
|
G |
UBE2F |
ubiquitin conjugating enzyme E2 F (putative) |
increases expression |
ISO |
Estriol results in increased expression of UBE2F mRNA |
CTD |
PMID:25575267 |
|
NCBI chr 2:237,967,014...238,042,782
Ensembl chr 2:237,966,827...238,042,782
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
EXP |
UGT1A1 protein results in increased glucuronidation of Estriol; UGT1A1 protein results in increased glucuronidation of Estriol analog |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
increases glucuronidation |
EXP |
UGT1A10 protein results in increased glucuronidation of Estriol; UGT1A10 protein results in increased glucuronidation of Estriol analog |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A3 |
UDP glucuronosyltransferase family 1 member A3 |
increases glucuronidation |
EXP |
UGT1A3 protein results in increased glucuronidation of Estriol; UGT1A3 protein results in increased glucuronidation of Estriol analog |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
|
|
G |
UGT1A7 |
UDP glucuronosyltransferase family 1 member A7 |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of Estriol; UGT1A7 protein results in increased glucuronidation of Estriol analog |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
|
|
G |
UGT1A8 |
UDP glucuronosyltransferase family 1 member A8 |
increases glucuronidation |
EXP |
UGT1A8 protein results in increased glucuronidation of Estriol; UGT1A8 protein results in increased glucuronidation of Estriol analog |
CTD |
PMID:15117964 |
|
NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300
|
|
G |
UGT2B11 |
UDP glucuronosyltransferase family 2 member B11 |
increases glucuronidation |
EXP |
UGT2B11 protein results in increased glucuronidation of Estriol |
CTD |
PMID:8333863 |
|
NCBI chr 4:69,199,951...69,224,984
Ensembl chr 4:69,199,951...69,214,748
|
|
G |
UGT2B15 |
UDP glucuronosyltransferase family 2 member B15 |
increases glucuronidation increases metabolic processing |
EXP |
UGT2B15 protein results in increased glucuronidation of Estriol UGT2B15 protein results in increased metabolism of Estriol |
CTD |
PMID:2116769 PMID:7835232 |
|
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
|
|
G |
UGT2B4 |
UDP glucuronosyltransferase family 2 member B4 |
increases glucuronidation |
EXP |
UGT2B4 protein results in increased glucuronidation of Estriol |
CTD |
PMID:1909626 |
|
NCBI chr 4:69,480,165...69,526,014
Ensembl chr 4:69,480,165...69,526,014
|
|
G |
UGT2B7 |
UDP glucuronosyltransferase family 2 member B7 |
increases glucuronidation |
EXP |
UGT2B7 protein alternative form results in increased glucuronidation of Estriol; UGT2B7 protein results in increased glucuronidation of Estriol |
CTD |
PMID:8423545 PMID:8517101 |
|
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
|
|
G |
UTP6 |
UTP6 small subunit processome component |
increases expression |
ISO |
Estriol results in increased expression of UTP6 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr17:31,860,904...31,901,708
Ensembl chr17:31,860,904...31,901,708
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP |
Estriol inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; Estriol inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; fulvestrant inhibits the reaction [Estriol inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] |
CTD |
PMID:12547825 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VDR |
vitamin D receptor |
increases expression |
EXP |
Estriol results in increased expression of VDR mRNA |
CTD |
PMID:14992164 PMID:15775415 |
|
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
|
|
G |
VEGFA |
vascular endothelial growth factor A |
increases expression |
ISO |
Estriol results in increased expression of VEGFA mRNA alternative form |
CTD |
PMID:8344219 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VTCN1 |
V-set domain containing T cell activation inhibitor 1 |
increases expression |
ISO |
Estriol results in increased expression of VTCN1 protein |
CTD |
PMID:21317386 |
|
NCBI chr 1:117,143,587...117,210,927
Ensembl chr 1:117,143,587...117,210,960
|
|
G |
WARS1 |
tryptophanyl-tRNA synthetase 1 |
increases expression |
EXP |
Estriol results in increased expression of WARS1 mRNA |
CTD |
PMID:15159206 |
|
NCBI chr14:100,333,790...100,376,327
Ensembl chr14:100,333,790...100,376,805
|
|
G |
ZNF688 |
zinc finger protein 688 |
decreases expression |
ISO |
Estriol results in decreased expression of ZFP688 mRNA |
CTD |
PMID:25575267 |
|
NCBI chr16:30,569,726...30,579,951
Ensembl chr16:30,569,672...30,572,734
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
ISO |
estriol-16 alpha-(beta-D-glucuronide) inhibits the reaction [ABCB1 results in increased transport of estradiol-17 beta-glucuronide] |
CTD |
PMID:9794924 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
|
G |
KL |
klotho |
multiple interactions increases hydrolysis |
ISO |
estriol 3-glucuronide inhibits the reaction [KL protein results in increased hydrolysis of Glucuronides] KL protein results in increased hydrolysis of estriol 3-glucuronide |
CTD |
PMID:14701853 |
|
NCBI chr13:33,016,243...33,066,143
Ensembl chr13:33,016,423...33,066,143
|
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
multiple interactions |
EXP |
Triamcinolone inhibits the reaction [ABCG2 protein affects the transport of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] |
CTD |
PMID:15365089 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
[Triamcinolone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein |
CTD |
PMID:29782964 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
Triamcinolone results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:15187100 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
AR |
androgen receptor |
multiple interactions |
EXP |
Triamcinolone binds to and results in increased activity of AR protein mutant form |
CTD |
PMID:11956172 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
CASP9 |
caspase 9 |
increases activity |
EXP |
Triamcinolone results in increased activity of CASP9 protein |
CTD |
PMID:11734450 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
Triamcinolone results in decreased expression of CCL2 protein |
CTD |
PMID:20116850 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
FABP4 |
fatty acid binding protein 4 |
multiple interactions |
EXP |
[Triamcinolone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein |
CTD |
PMID:29782964 |
|
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
|
|
G |
HPGD |
15-hydroxyprostaglandin dehydrogenase |
multiple interactions |
EXP |
Triamcinolone results in increased expression of and results in increased activity of HPGD protein |
CTD |
PMID:15680906 |
|
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
|
|
G |
INS |
insulin |
multiple interactions |
EXP |
[Triamcinolone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Triamcinolone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein |
CTD |
PMID:29782964 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
MB |
myoglobin |
increases secretion |
ISO |
Triamcinolone results in increased secretion of MB protein |
CTD |
PMID:19628585 |
|
NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
multiple interactions increases activity |
EXP |
NR3C1 protein alternative form inhibits the reaction [Triamcinolone results in increased activity of NR3C1 protein alternative form]; Triamcinolone binds to and results in increased activity of NR3C1 protein |
CTD |
PMID:11956172 PMID:15362971 PMID:15755863 PMID:21543282 |
|
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
|
|
G |
NR3C2 |
nuclear receptor subfamily 3 group C member 2 |
decreases activity increases activity |
EXP |
Triamcinolone results in decreased activity of NR3C2 protein Triamcinolone results in increased activity of NR3C2 protein |
CTD |
PMID:15362971 |
|
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
|
|
G |
PGR |
progesterone receptor |
multiple interactions |
EXP |
Triamcinolone binds to and results in increased activity of PGR protein |
CTD |
PMID:25752796 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
POMC |
proopiomelanocortin |
decreases response to substance |
EXP |
Triamcinolone results in decreased susceptibility to POMC protein modified form |
CTD |
PMID:7788158 |
|
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
|
|
G |
VEGFA |
vascular endothelial growth factor A |
decreases expression |
EXP |
Triamcinolone results in decreased expression of VEGFA protein |
CTD |
PMID:20116850 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
affects transport |
ISO |
ABCB1A protein affects the transport of Triamcinolone Acetonide |
CTD |
PMID:16105236 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
BAD |
BCL2 associated agonist of cell death |
increases expression |
ISO |
Triamcinolone Acetonide results in increased expression of BAD protein |
CTD |
PMID:15987869 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Triamcinolone Acetonide results in increased expression of BAX protein |
CTD |
PMID:15987869 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BID |
BH3 interacting domain death agonist |
increases expression |
ISO |
Triamcinolone Acetonide results in increased expression of BID protein |
CTD |
PMID:15987869 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
CASP8 |
caspase 8 |
increases activity |
ISO |
Triamcinolone Acetonide results in increased activity of CASP8 protein |
CTD |
PMID:15987869 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
multiple interactions |
EXP |
Triamcinolone Acetonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] |
CTD |
PMID:10903220 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCN2 |
cellular communication network factor 2 |
multiple interactions |
EXP |
Triamcinolone Acetonide promotes the reaction [Paraquat results in increased expression of CCN2 mRNA] |
CTD |
PMID:15728566 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions decreases secretion |
EXP |
Triamcinolone Acetonide inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] Triamcinolone Acetonide results in decreased secretion of CSF2 protein |
CTD |
PMID:10460758 PMID:10868704 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CYP2S1 |
cytochrome P450 family 2 subfamily S member 1 |
decreases expression |
EXP |
Triamcinolone Acetonide results in decreased expression of CYP2S1 mRNA |
CTD |
PMID:22155357 |
|
NCBI chr19:41,193,219...41,207,539
Ensembl chr19:41,193,210...41,207,539
|
|
G |
CYP3A5 |
cytochrome P450 family 3 subfamily A member 5 |
increases expression multiple interactions |
EXP |
Triamcinolone Acetonide results in increased expression of CYP3A5 mRNA Ketoconazole inhibits the reaction [Triamcinolone Acetonide results in increased expression of CYP3A5 mRNA] |
CTD |
PMID:24555085 |
|
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
|
|
G |
FADD |
Fas associated via death domain |
increases expression |
ISO |
Triamcinolone Acetonide results in increased expression of FADD protein |
CTD |
PMID:15987869 |
|
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP |
Triamcinolone Acetonide inhibits the reaction [IL1B protein results in increased abundance of Thromboxane B2]; Triamcinolone Acetonide inhibits the reaction [IL1B protein results in increased expression of TNF protein]; Triamcinolone Acetonide inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Triamcinolone Acetonide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] |
CTD |
PMID:10460758 PMID:15337628 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
Triamcinolone Acetonide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of IL6 mRNA] |
CTD |
PMID:27916735 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
decreases expression |
EXP |
Triamcinolone Acetonide results in decreased expression of MKI67 protein |
CTD |
PMID:16029572 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
Triamcinolone Acetonide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MUC5AC mRNA] |
CTD |
PMID:27916735 |
|
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
multiple interactions affects binding decreases expression |
EXP ISO |
[Triamcinolone Acetonide binds to NR3C1 protein] which results in decreased secretion of VEGFA protein; Triamcinolone Acetonide binds to and affects the localization of NR3C1 protein Dithiothreitol inhibits the reaction [Mercuric Chloride inhibits the reaction [Triamcinolone Acetonide binds to NR3C1 protein]]; Mercuric Chloride inhibits the reaction [Triamcinolone Acetonide binds to NR3C1 protein]; Triamcinolone Acetonide binds to and affects the activity of NR3C1 protein Triamcinolone Acetonide results in decreased expression of NR3C1 protein Triamcinolone Acetonide analog binds to NR3C1 protein; Triamcinolone Acetonide binds to NR3C1 protein |
CTD |
PMID:926113 PMID:15250541 PMID:15705660 PMID:15976447 PMID:16029572 PMID:16507850 PMID:23765520 More...
|
|
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
|
|
G |
PLA2G4A |
phospholipase A2 group IVA |
decreases activity |
EXP |
Triamcinolone Acetonide results in decreased activity of PLA2G4A protein |
CTD |
PMID:15337628 |
|
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
|
|
G |
SERPINB1 |
serpin family B member 1 |
multiple interactions |
ISO EXP |
Triamcinolone Acetonide results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form Triamcinolone Acetonide results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form |
CTD |
PMID:25447644 |
|
NCBI chr 6:2,832,332...2,841,863
Ensembl chr 6:2,832,332...2,841,959
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
multiple interactions |
EXP |
Triamcinolone Acetonide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
SULT1A1 |
sulfotransferase family 1A member 1 |
increases expression |
ISO |
Triamcinolone Acetonide results in increased expression of SULT1A1 mRNA; Triamcinolone Acetonide results in increased expression of SULT1A1 protein |
CTD |
PMID:10799342 |
|
NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
EXP |
Triamcinolone Acetonide inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA] |
CTD |
PMID:15728566 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP ISO |
Triamcinolone Acetonide inhibits the reaction [IL1B protein results in increased expression of TNF protein]; Triamcinolone Acetonide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Triamcinolone Acetonide inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Triamcinolone Acetonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] Triamcinolone Acetonide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TNF mRNA] |
CTD |
PMID:10100995 PMID:10903220 PMID:15337628 PMID:27916735 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP |
Triamcinolone Acetonide inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
CTD |
PMID:10100995 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions decreases expression |
EXP |
[Triamcinolone Acetonide binds to NR3C1 protein] which results in decreased secretion of VEGFA protein; Triamcinolone Acetonide inhibits the reaction [cobaltous chloride results in increased expression of VEGFA mRNA]; Triamcinolone Acetonide inhibits the reaction [cobaltous chloride results in increased secretion of VEGFA protein]; Triamcinolone Acetonide inhibits the reaction [Paraquat results in increased expression of VEGFA mRNA] Triamcinolone Acetonide results in decreased expression of VEGFA protein |
CTD |
PMID:15728566 PMID:16029572 PMID:16249516 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|